Anti-hormonal therapy in breast cancer
Ecker-Schlipf, B.
Medizinische Monatsschrift für Pharmazeuten 17(8): 247-250
1994
ISSN/ISBN: 0342-9601 PMID: 7935152 Document Number: 425406
Document emailed within 1 workday
Related Documents
Friedrich, M. 2000: Vitamin D and breast cancer: new approaches for hormonal therapy of breast cancer Clinical and Experimental Obstetrics and Gynecology 27(2): 77-82Murphy, B.; Muss, H.B. 1997: Hormonal therapy of breast cancer: state of the art Oncology 11(5 Suppl 4: 7-13
This, P. 2005: Hormonal replacement therapy and breast cancer La Revue du Praticien 55(4): 377-382
Hortobagyi, G.N.; DiStefano, A.; Legha, S.S.; Buzdar, A.U.; Blumenschein, G.R. 1979: Hormonal therapy with tamoxifen in male breast cancer Cancer Treatment Reports 63(4): 539-541
Predná, L.; Habánová, M.; Sláviková, E.; Wyka, J. 2015: Hormonal contraceptives and hormone replacement therapy as a possible factor of breast cancer Roczniki Panstwowego Zakladu Higieny 66(3): 269-274
Johnson, P.A.; Muss, H.; Bonomi, P.; Von Roenn, J.; Wolter, J.; Paschold, E.; Black, W.; Cooper, M. 1988: Megestrol acetate as primary hormonal therapy for advanced breast cancer Seminars in Oncology 15(2 Suppl 1: 34-37
Saito, K.; Hotta, T.; Kobayashi, S.; Miura, I.; Sakuma, S.; Shimozato, T.; Torii, T.; Iwase, H.; Satake, A.; Nishida, T. 1985: A case of male breast cancer with special reference to the hormonal environment during chemoendocrine therapy Gan no Rinsho. Japan Journal of Cancer Clinics 31(13): 1727-1730
Schilder, C.M.T.; Schagen, S.B. 2007: Effects of hormonal therapy on cognitive functioning in breast cancer patients: a review of the literature Minerva Ginecologica 59(4): 387-401
Sakuta, M.; Sumiyama, Y.; Okamoto, Y.; Noto, Y.; Naka, I.; Kiribayashi, T. 2002: A case of locally recurrent breast cancer in which phlebothrombosis of the right leg after hormonal therapy using a high dose of toremifene citrate Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(1): 115-118
Brand, F-Xavier.; Ravanel, N.; Gauchez, A-Sophie.; Pasquier, D.; Payan, R.; Fagret, D.; Mousseau, M. 2006: Prospect for anti-HER2 receptor therapy in breast cancer Anticancer Research 26(1b): 463-470
Lai, J.-N.; Wu, C.-T.; Chen, P.-C.; Huang, C.-S.; Chow, S.-N.; Wang, J.-D. 2011: Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008 Plos one 6(10): E25183
Yamashita, T.; Iwata, K. 2009: New development in the treatment of breast cancer. II. Future anti-HER2 therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(13): 2551-2554
Von Minckwitz, G.; Loibl, S.; Untch, M. 2012: What is the current standard of care for anti-HER2 neoadjuvant therapy in breast cancer? Oncology 26(1): 20-26
Caceres, G.; Dauphinee, M.J.; Eisele, L.E.; MacColl, R.; Mizejewski, G.J. 2002: Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein Anticancer Research 22(5): 2817-2820
Lanfranchi, A. 2014: Normal breast physiology: the reasons hormonal contraceptives and induced abortion increase breast-cancer risk Issues in Law and Medicine 29(1): 135-146
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Meiss, L.; Djandji, V.; Raute, M.; Kühn, W. 1974: Therapy of breast carcinoma. Surgical, radiologic and hormonal treatment of a patient with breast carcinoma metastases. Clinical course with regard to pre-terminal immunoglobulin and complement changes Fortschritte der Medizin 92(14): 615-616
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104